Sage Journals: Discover world-class research

Open access

Review article

First published 2021

Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer

Daisuke Kotani, Kohei Shitara

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases

Astrid Medhus, Kay Oliver Schink, Ane Sager Longva [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2023

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Yuan Yuan, Colt Egelston, Oscar Colunga Flores [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer

Jiangping Yang, Jiaqi Han, Ni Zeng [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings

Koshiro Fukuda, Hiroki Osumi, Keitaro Shimozaki [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2026

Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study

Yukiya Narita, Ryosuke Kumanishi, Koshi Takahashi [...]

Therapeutic Advances in Gastroenterology

Retricted access

Review article

First published 2025

Trastuzumab deruxtecan: An antibody-drug conjugates for non-small cell lung cancer

Nahida Siddiqui, Gojuvaka Sravanthi, Kanugonda Jashwanth Kumar Reddy [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter,observational,real-world study

Die Sang, Yanfang Su, Yurong Zhang [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2023

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm

Charlie Yang, Christine Brezden-Masley, Anil Abraham Joy [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons, Daniel Rayson, Anil Abraham Joy [...]

Therapeutic Advances in Medical Oncology

Search results